Gainers:
Biogen Idec Inc. (BIIB) is gaining over 1 percent to $185.50 based on the news that the FDA has granted approval to TECFIDERA, its first-line oral drug for the treatment of people living with relapsing forms of multiple sclerosis in the U.S.
Decliners:
BlackBerry (BBRY) is down more than 1 percent to $14.32. The company swung to a profit in its fourth quarter. Revenue declined from the previous year period, while gross margin improved driven by higher average selling prices and hardware margins. The company shipped approximately 6 million BlackBerry smartphones and approximately 370 thousand BlackBerry PlayBook tablets during the fourth quarter. Including the anticipated 50 percent sequential increase in marketing spending, the company expects to approach breakeven financial results in the first quarter based on its lower cost base, more efficient supply chain, and improved hardware margins.
Accenture plc (ACN) is declining 3 percent to $72.74. The company's second quarter profit improved from the last year period and topped Wall Street view. Net revenues rose 4 percent, but were slightly below the consensus estimate. Meanwhile, the company forecast third quarter net revenues below the consensus estimate.
GameStop Corp. (GME) is down over 6 percent to $24.70. The company's fourth quarter profit and sales were above Wall Street view. Consolidated comparable store sales decreased 4.6 percent. GameStop expects the first half of the year to be challenging as consumers postpone purchases leading up to the fourth quarter console launch.
Five Below, Inc. (FIVE) is falling 6 percent to $36.78 following the release of its quarterly results.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.